chr5-73068681-A-G

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_138782.3(FCHO2):ā€‹c.1481A>Gā€‹(p.Asn494Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000595 in 1,612,148 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000020 ( 0 hom., cov: 32)
Exomes š‘“: 0.000064 ( 0 hom. )

Consequence

FCHO2
NM_138782.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.38
Variant links:
Genes affected
FCHO2 (HGNC:25180): (FCH and mu domain containing endocytic adaptor 2) Enables identical protein binding activity. Involved in clathrin coat assembly and clathrin-dependent endocytosis. Located in clathrin-coated pit and clathrin-coated vesicle. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.04793498).
BS2
High AC in GnomAdExome4 at 93 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FCHO2NM_138782.3 linkuse as main transcriptc.1481A>G p.Asn494Ser missense_variant 19/26 ENST00000430046.7 NP_620137.2 Q0JRZ9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FCHO2ENST00000430046.7 linkuse as main transcriptc.1481A>G p.Asn494Ser missense_variant 19/261 NM_138782.3 ENSP00000393776.2 Q0JRZ9-1
FCHO2ENST00000512348.5 linkuse as main transcriptc.1382A>G p.Asn461Ser missense_variant 18/252 ENSP00000427296.1 Q0JRZ9-3
FCHO2ENST00000508431.1 linkuse as main transcriptn.240A>G non_coding_transcript_exon_variant 3/54

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
151990
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000563
AC:
14
AN:
248626
Hom.:
0
AF XY:
0.00000741
AC XY:
1
AN XY:
134876
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000299
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000976
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000637
AC:
93
AN:
1460158
Hom.:
0
Cov.:
30
AF XY:
0.0000606
AC XY:
44
AN XY:
726388
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.000345
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000729
Gnomad4 OTH exome
AF:
0.0000498
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
151990
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74226
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.000289
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000769
Hom.:
0
Bravo
AF:
0.0000416
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000121
AC:
1
ExAC
AF:
0.0000496
AC:
6
EpiCase
AF:
0.000273
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 27, 2023The c.1481A>G (p.N494S) alteration is located in exon 19 (coding exon 19) of the FCHO2 gene. This alteration results from a A to G substitution at nucleotide position 1481, causing the asparagine (N) at amino acid position 494 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
14
DANN
Benign
0.75
DEOGEN2
Benign
0.00095
T;.
Eigen
Benign
-0.64
Eigen_PC
Benign
-0.46
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Uncertain
0.89
D;D
M_CAP
Benign
0.0042
T
MetaRNN
Benign
0.048
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L;.
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.14
N;N
REVEL
Benign
0.039
Sift
Benign
0.81
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.0030
B;.
Vest4
0.22
MVP
0.51
MPC
0.20
ClinPred
0.015
T
GERP RS
0.93
Varity_R
0.024
gMVP
0.46

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201594850; hg19: chr5-72364508; API